Bioresorbable Polymers Market to Reach USD 4.73 Billion by 2032, Driven by Rising Demand in Medical and Orthopedic Applications

The global [*Bioresorbable Polymers Market*](https://www.snsinsider.com/reports/bioresorbable-polymers-market-2133) is projected to experience remarkable growth in the coming years, with the market size expected to increase from USD 1.49 billion in 2023 to USD 4.73 billion by 2032. This represents a compound annual growth rate (CAGR) of 13.70% over the forecast period from 2024 to 2032. The increasing adoption of bioresorbable polymers in medical applications, particularly in orthopedic devices and drug delivery systems, is fueling this expansion.

### **Bioresorbable Polymers Overview**

Bioresorbable polymers are materials that break down and are absorbed naturally by the body over time, eliminating the need for surgical removal. These materials are widely used in medical devices and drug delivery systems because they reduce the risk of complications and improve patient outcomes. They are primarily utilized in temporary applications, such as sutures, stents, and orthopedic implants, where the polymer gradually dissolves after fulfilling its purpose.

### **Market Segmentation**

#### **By Type:**

l **Polylactic Acid (PLA)**: PLA is a biodegradable polymer derived from renewable sources such as corn starch or sugarcane. It is one of the most widely used bioresorbable polymers due to its biocompatibility and high strength, making it suitable for medical implants, sutures, and drug delivery systems.

l **Polysaccharides**: These natural polymers, including chitosan and hyaluronic acid, are increasingly being used in biomedical applications due to their excellent biocompatibility, ability to promote wound healing, and use in tissue engineering.

l **Proteins**: Protein-based bioresorbable polymers, such as collagen and fibrin, are being utilized in regenerative medicine, tissue scaffolding, and drug delivery due to their natural compatibility with human tissues.

l **Polyglycolic Acid (PGA)**: PGA is a highly crystalline bioresorbable polymer known for its fast degradation rate, making it ideal for applications like sutures and temporary scaffolds.

l **Poly (Lactic-Co-Glycolic Acid) (PLGA)**: PLGA is a copolymer of lactic and glycolic acids, which offers controlled degradation rates. It is highly used in drug delivery systems and controlled-release applications.

l **Polycaprolactone (PCL)**: PCL is a slow-degrading polymer that is frequently used in long-term drug delivery, tissue engineering, and wound dressings.

l **Others**: Other bioresorbable polymers include polyhydroxybutyrate (PHB), polyurethanes, and various copolymers that offer specialized properties for niche applications in medical and pharmaceutical fields.

#### **By Application:**

l **Orthopedic Devices**: Bioresorbable polymers are widely used in the manufacturing of orthopedic implants, screws, pins, and plates. These materials provide the necessary support for bone healing and degrade once their function is complete, eliminating the need for additional surgeries to remove implants.

l **Drug Delivery**: In the field of drug delivery, bioresorbable polymers are used to create systems that release drugs at a controlled rate. This ensures precise dosing and reduces the frequency of administration. These systems are widely applied in cancer treatment, cardiovascular diseases, and tissue engineering.

l **Others**: Other applications include wound healing, cardiovascular stents, dental devices, and tissue regeneration. The versatility of bioresorbable polymers in these applications is driving increased demand from various healthcare sectors.

#### **By Region:**

l **North America**: North America dominates the bioresorbable polymers market due to the well-established healthcare infrastructure, rising healthcare expenditures, and increasing demand for advanced medical devices. The region's focus on innovation and regulatory support for biodegradable products further accelerates market growth.

l **Europe**: Europe holds a significant share of the market, driven by the presence of leading pharmaceutical and medical device manufacturers, stringent regulations promoting sustainable products, and the region's robust R&D capabilities in biotechnology.

l **Asia-Pacific**: The Asia-Pacific region is expected to witness the fastest growth, primarily due to expanding healthcare sectors in countries like China, India, and Japan. Rising disposable incomes, growing awareness of advanced medical treatments, and an increasing elderly population are boosting demand for bioresorbable polymers in the region.

l **Rest of the World**: Regions such as Latin America, the Middle East, and Africa are also experiencing growth, particularly with increased government spending on healthcare infrastructure and the growing adoption of advanced medical technologies.

### **Market Drivers**

l **Growing Demand for Minimally Invasive Procedures**: As minimally invasive surgeries become more popular due to their faster recovery times and lower complication rates, the demand for bioresorbable materials used in such procedures continues to rise. These polymers are used in temporary implants, stents, and sutures, providing the necessary support and then gradually being absorbed by the body.

l **Increasing Use in Drug Delivery Systems**: Bioresorbable polymers offer significant advantages in drug delivery, particularly in the development of controlled-release systems. The ability to release drugs at a consistent rate over time reduces the need for frequent dosing, improving patient compliance and treatment efficacy.

l **Rising Geriatric Population**: The global aging population is a key driver of demand for bioresorbable polymers, especially in orthopedic and cardiovascular applications. As the elderly population grows, the need for surgical interventions and implants that reduce the risk of complications is increasing.

l **Advancements in Biotechnology and Material Science**: Technological advancements in material science are leading to the development of new bioresorbable polymers with enhanced properties, such as improved mechanical strength and tailored degradation rates. These innovations are expanding the range of applications for bioresorbable polymers in medical devices and pharmaceuticals.

l **Increasing Focus on Sustainability**: As the medical and healthcare sectors shift towards more sustainable solutions, bioresorbable polymers are becoming more attractive due to their ability to degrade naturally and reduce the environmental impact of medical waste. Governments and regulatory bodies are also encouraging the use of biodegradable materials in medical devices.

### **Recent Developments**

l **Innovation in Orthopedic Devices**: In 2023, *Poly-Med Inc.* launched a new line of bioresorbable orthopedic screws designed for enhanced bone regeneration. These screws provide the necessary support during the healing process and degrade over time, eliminating the need for removal surgery.

l **Advancements in Drug Delivery Systems**: *Evonik Industries AG* has developed a new bioresorbable polymer for long-term drug delivery, specifically designed to improve the stability and release profiles of highly sensitive biologic drugs. This breakthrough offers greater precision in drug dosing and extends the application of bioresorbable materials in pharmaceutical formulations.

l **Mergers and Acquisitions**: In recent years, major players like *Foster Corporation*and *Corbion NV* have expanded their product portfolios by acquiring smaller companies specializing in bioresorbable technologies. These acquisitions aim to strengthen their market position and broaden their offerings in the medical and pharmaceutical sectors.

### **Competitive Landscape**

The global bioresorbable polymers market is highly competitive, with numerous players actively innovating and expanding their product portfolios to meet growing demand. Some of the key players driving market growth include:

- *Putnam Plastics (US)*

- *Evonik Industries AG (Germany)*

- *Ashland (US)*

- *DURECT CORPORATION (US)*

- *REVA Medical, Inc. (US)*

- *Poly-Med Inc. (US)*

- *Merck KGaA (Germany)*

- *KLS Martin (US)*

- *Corbion NV (The Netherlands)*

- *Koninklijke DSM N.V (The Netherlands)*

- *Foster Corporation (US)*

- *Groupe PCAS (France)*

### **Conclusion**

The *Bioresorbable Polymers Market* is poised for robust growth through 2032, driven by rising demand in medical and pharmaceutical applications. The increasing focus on minimally invasive procedures, advancements in drug delivery systems, and growing awareness of sustainability are key factors contributing to this expansion. With ongoing innovations and an expanding range of applications, bioresorbable polymers are expected to play a critical role in the future of medical technology.

**About Us**:

**SNS Insider** is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

**Contact Us:**

**Akash Anand -- Head of Business Development & Strategy**

[**info@snsinsider.com**](mailto:info@snsinsider.com)

**Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)**